JUST IN: Positive topline results from our Phase 3 BROOKLYN study of obicetrapib, our investigational CETP inhibitor, in patients with heterozygous familial hypercholesterolemia (HeFH). https://bit.ly/3LKFu3M
NewAmsterdam Pharma Corporation
Biotechnology
Aventura, Florida 7,891 followers
NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabolic diseases.
About us
This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally tolerated statin therapy.
- Website
-
https://www.newamsterdampharma.com
External link for NewAmsterdam Pharma Corporation
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Aventura, Florida
- Type
- Public Company
- Founded
- 2019
Locations
-
Primary
Aventura, Florida, US
Employees at NewAmsterdam Pharma Corporation
Updates
-
A recent study published in the European Journal of Preventive Cardiology concludes that lifetime exposure to LDL-C determines coronary plaque burden in familial hypercholesterolemia (FH). https://bit.ly/3ZiUEW2
-
Our team is energized after connecting with many of the 32,000 participants from 171 countries at this year’s #ESCCongress. We’re encouraged by the conversations around fighting clinical inertia to get more patients closer to their risk-based LDL-C goals.
-
Listen in to a fireside chat with our Chief Financial Officer, M. Ian Somaiya, live from the Morgan Stanley Global Healthcare Conference at 10 a.m. ET. https://bit.ly/3XetnBo
-
Healthy adults over age 20 should have their cholesterol checked at least once every five years, according to the Foundation of the National Lipid Association. If it’s been a minute, talk to your doctor. This simple blood test is essential for understanding your risk of cardiovascular disease. https://bit.ly/3JOG8fJ
-
This week, we’re hosting two CME-accredited symposia at #ESCCongress2024 covering CETP as a therapeutic target in the clinical management of LDL-C and the use of novel therapies in LDL-C lowering. https://bit.ly/4dzvZRf
-
Take it from Aletha: If heart disease runs in your family, you need to know if genetic conditions like familial hypercholesterolemia and elevated Lp(a) could be adding to your cardiovascular risk. Family Heart Foundation
Thank you to Aletha for sharing your story! #Runsinthefamily is NOT a diagnosis. Familial Hypercholesterolemia and high Lipoprotein(a) affects families and children! Visit morefamiliesmorehearts.org to see if your family could be at risk for genetic heart disease or stroke. #Youdeservetoknow #KnowFH #KnowLpa #morefamiliesmorehearts
-
From American Society for Preventive Cardiology (ASPC): “Lower [LDL-C] for longer is better, and achieving very low LDL-C is feasible and safe.” https://bit.ly/4cHOwK4
-
A meta-analysis published in The Lancet found high-intensity statins were more likely to increase glycemia compared to low- or moderate-intensity options, raising vulnerability for patients already nearing the threshold for diabetes. https://bit.ly/3WSJdRP
-
For the 1 in every 250 Americans who have familial hypercholesterolemia (FH), high LDL-C is in their genes. This inherited condition means they’re born with high LDL-C and levels only get higher with time. We appreciate Katherine Wilemon, founder of the Family Heart Foundation, for sharing her story with TIME to raise awareness of FH. https://lnkd.in/gGD5E3cs